Ajanta Pharma Limited's latest marketcap:
As of 08/16/2025, Ajanta Pharma Limited's market capitalization has reached $3.83 B. According to our data, Ajanta Pharma Limited is the 4177th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 3.83 B |
| Revenue (ttm) | 549.19 M |
| Net Income (ttm) | 106.27 M |
| Shares Out | 124.89 M |
| EPS (ttm) | 0.85 |
| Forward PE | 31.31 |
| Ex-Dividend Date | 11/06/2024 |
| Earnings Date | 07/27/2025 |
Ajanta Pharma Limited's yearly market capitalization.
| Date | Market Cap(₹) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 08/16/2025 | ₹335.44 B | $3.83 B | -8.4% | 4177 |
| 12/31/2024 | ₹366.2 B | $4.28 B | 39.58% | 3358 |
| 12/29/2023 | ₹262.36 B | $3.15 B | 68.96% | 4121 |
| 12/30/2022 | ₹155.28 B | $1.88 B | -19.73% | 5577 |
| 12/31/2021 | ₹193.46 B | $2.6 B | 36.89% | 5225 |
| 12/31/2020 | ₹141.32 B | $1.93 B | 66.18% | 5451 |
| 12/31/2019 | ₹85.04 B | $1.19 B | -18.52% | 6172 |
| 12/31/2018 | ₹104.37 B | $1.5 B | -20.49% | 4805 |
| 12/29/2017 | ₹131.27 B | $2.06 B | -16.33% | 4501 |
| 12/30/2016 | ₹156.9 B | $2.31 B | 33.87% | 3572 |
Company Profile
About Ajanta Pharma Limited
Ajanta Pharma Limited is a leading specialty pharmaceutical formulation company engaged in the development, manufacturing, and marketing of high-quality finished dosages. With a strong presence in both domestic and international markets, the company is committed to delivering innovative healthcare solutions.
Therapeutic Segments
Ajanta Pharma serves a diverse range of therapeutic areas, including:
- Cardiology
- Antidiabetic
- Ophthalmology
- Dermatology
- Pain Management
- Respiratory Care
Product Portfolio
The company offers a comprehensive range of pharmaceutical products, such as:
- Tablets & Capsules
- Injectables
- Inhalers
- Ointments & Creams
- Liquids
Global Presence
Ajanta Pharma operates across multiple regions, including:
- India
- Africa
- Rest of Asia
- United States
- International Markets
Company Background
Founded in 1973, Ajanta Pharma Limited is headquartered in Mumbai, India. The company has established itself as a trusted name in the pharmaceutical industry through its commitment to research, quality, and patient care.
Frequently Asked Questions
-
What is Ajanta Pharma Limited's (NSE-AJANTPHARM) current market cap?As of 08/16/2025, Ajanta Pharma Limited (including the parent company, if applicable) has an estimated market capitalization of $3.83 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Ajanta Pharma Limited (NSE-AJANTPHARM) rank globally by market cap?Ajanta Pharma Limited global market capitalization ranking is approximately 4177 as of 08/16/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.